Search Results - "Frye, Laura J."

Postpartum infection, pain and experiences with care among women treated for postpartum hemorrhage in three African countries: A cohort study of women managed with and without condom-catheter uterine balloon tamponade by Anger, Holly A, Durocher, Jill, Dabash, Rasha, Hassanein, Nevine, Ononge, Sam, Burkhardt, Gillian, Frye, Laura J, Diop, Ayisha, Beye Diop, Seynabou Bop Moctar, Darwish, Emad, Ramadan, Mohamed Cherine, Kayaga, Juliana, Charles, Dyanna, Gaye, Alioune, Eckardt, Melody, Winikoff, Beverly

“…We aimed to determine the risk of postpartum infection and increased pain associated with use of condom-catheter uterine balloon tamponade (UBT) among women…”
Get full text

A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally by Durocher, Jill, Kilfedder, Catherine, Frye, Laura J., Winikoff, Beverly, Srinivasan, Karthik

“…Pharmacies in low- and middle-income countries play an important role in increasing the availability of medical abortion to individuals for self-use. We aimed…”
Get full text

Comment on "Is It Safe to Provide Abortion Pills Over The Counter? A Study on Outcome Following Self-Medication with Abortion Pills" by Frye, Laura J, Winikoff, Beverly

Get full text

Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol by Ditai, James, Frye, Laura J, Durocher, Jill, Byrne, Meagan E, Ononge, Sam, Winikoff, Beverly, Weeks, Andrew D

“…Advance provision of misoprostol to women during antenatal care aims to achieve broader access to uterotonics for the prevention of postpartum hemorrhage…”
Get full text

A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries by Frye, Laura J., Kilfedder, Catherine, Blum, Jennifer, Winikoff, Beverly

“…To evaluate the characteristics, clinical information, and storage instructions contained in package inserts from medical abortion commodities collected in…”
Get full text

Abortion bans and their impacts: A view from the United States by Frye, Laura J, Winikoff, Beverly

“…A retrospective study of abortion facilities in and around Texas by White et al. and a spatial analysis by Rader et al. are combined to illustrate the…”
Get full text

Authors' reply re: The effectiveness and safety of introducing condom-catheter uterine balloon tamponade for postpartum hemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped-wedge, cluster-randomized trial: Effectiveness trial on introducing condom-catheter UBT suggests a refocus on systems issues around PPH care by Frye, Laura J, Anger, Holly A, Burkhardt, Gillian

Get full text

Profound Hyperthermia After Postpartum Rectal Misoprostol Administration by Durocher, Jill, Frye, Laura J., Winikoff, Beverly

Get full text

Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study by Raymond, Elizabeth G., Frye, Laura J., Tocce, Kristina, Gingras, Shay, Almquist, Amy, Firstenberg, Ann, Ortega, Cynthia, Blumenthal, Paul D., Winikoff, Beverly, Boraas, Christy

“…This study aimed to assess the feasibility, safety, and acceptability of asynchronous screening for medication abortion eligibility using a programmed…”
Get full text

A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S by Chong, Erica, Frye, Laura J, Castle, Jen, Dean, Gillian, Kuehl, Laurel, Winikoff, Beverly

“…Abstract Objective To determine the acceptability of taking mifepristone at home for early medical abortion in the United States. Study design This…”
Get full text

Single dose letrozole and misoprostol for termination of pregnancy through 63 days’ gestation: A pilot study by Shochet, Tara, Turok, David, Frye, Laura J., Sexsmith, Corinne D., Gawron, Lori M., Kaiser, Jennifer E., Winikoff, Beverly

“…We conducted a pilot study to evaluate a single dose of letrozole 30 mg prior to misoprostol 800 mcg buccally for medication abortion We enrolled 40…”
Get full text

PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use population by Frye, Laura J, Buhimschi, Irina A, Raymond, Elizabeth G, Zhao, Guomao, Winikoff, Beverly

“…Prior studies indicate that PAPP-A could serve as a marker of gestational age (GA) with the potential to determine eligibility for medication abortion. The…”
Get full text

Sensitivity and specificity of placental proteins for gestational age screening: An exploratory study by Raymond, Elizabeth G., Frye, Laura J., Weaver, Mark A., Lebed, Joel P., Ren, Xiangdong, Steider, Elizabeth, Winikoff, Beverly, Barnhart, Kurt T.

“…To examine the possibility that serum or urine concentrations of pregnancy-associated plasma protein A (PAPP-A), a disintegrin and metalloproteinase 12…”
Get full text

In Reply to PAPP-A Results Cannot Be Used to Accurately Estimate Gestational Age by Buhimschi, Irina A, Frye, Laura J, Winikoff, Beverly, Raymond, Elizabeth G

Get full text

Claims of misoprostol use based on blood sampling should be viewed with skepticism by Frye, Laura J, Winikoff, Beverly, Meckstroth, Karen

“…Abstract Efforts to prosecute women for induced abortion have included allegations that misoprostol was found in body fluids. These claims, however, are…”
Get full text

Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational Age by Buhimschi, Irina A, Zhao, Guomao, El Helou, Yara, Frye, Laura J, Winikoff, Beverly, Raymond, Elizabeth G

“…Accurate pregnancy dating is critical for maternal and child health and for counseling on safe and effective abortion methods. While last menstrual period and…”
Get full text

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes by Frye, Laura J., Byrne, Meagan E., Winikoff, Beverly

“…Objectives: The aim of the study was to compare the pharmacokinetic parameters of 800 μg oral, sublingual and buccal misoprostol in healthy non-pregnant women…”
Get full text

What happens when we routinely give doxycycline to medical abortion patients? by Frye, Laura J, Chong, Erica, Winikoff, Beverly

“…Abstract Objectives Routine provision of antibiotics following medical abortion is common yet practitioners and professional societies differ on its utility…”
Get full text

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial by Weeks, Andrew D, Ditai, James, Ononge, Sam, Faragher, Brian, Frye, Laura J, Durocher, Jill, Mirembe, Florence M, Byamugisha, Josaphat, Winikoff, Beverly, Alfirevic, Zarko

“…600 mcg of oral misoprostol reduces the incidence of postpartum haemorrhage (PPH), but in previous research this medication has been administered by health…”
Get full text

Authors' reply re: The effectiveness and safety of introducing condom‐catheter uterine balloon tamponade for postpartum hemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped‐wedge, cluster‐randomized trial by Frye, Laura J., Anger, Holly A., Burkhardt, Gillian

Get full text